Abstract Trisomy 18 is a common human aneuploidy that is associated with signiWcant perinatal mortality. Unlike the well-characterized "critical region" in trisomy 21 (21q22), there is no corresponding region on chromosome 18 associated with its pathogenesis. The high morbidity and mortality of aVected individuals has limited extensive investigations. In order to better understand the molecular mechanisms underlying the congenital anomalies observed in this condition, we investigated the in utero gene expression proWle of second trimester fetuses aVected with trisomy 18. Total RNA was extracted from cell-free amniotic Xuid supernatant from aneuploid fetuses and euploid controls matched for gestational age and hybridized to AVymetrix U133 Plus 2.0 arrays. Individual diVerentially expressed transcripts were obtained by two-tailed t tests. Over-represented functional pathways among these genes were identiWed with DAVID and Ingenuity ® Pathways Analysis. Results show that three hundred and Wfty-two probe sets representing 251 annotated genes were statistically signiWcantly diVerentially expressed between trisomy 18 and controls. Only 7 genes (2.8% of the annotated total) were located on chromosome 18, including ROCK1, an upregulated gene involved in valvuloseptal and endocardial cushion formation. Pathway analysis indicated disrupted function in ion transport, MHCII/T cell mediated immunity, DNA repair, G-protein mediated signaling, kinases, and glycosylation. SigniWcant down-regulation of genes involved in adrenal development was identiWed, which may explain both the abnormal maternal serum estriols and the pre and postnatal growth restriction in trisomy 18. Comparison of this gene set to one previously generated for trisomy 21 fetuses revealed only six overlapping diVerentially regulated genes. This study contributes novel information regarding functional developmental gene expression diVerences in fetuses with trisomy 18.
Introduction
Trisomy 18 (Edwards syndrome) is a common human aneuploidy, with a fetal prevalence of 1 in 4,272 at 18 weeks and a live born prevalence of 1 in 8,333 (Embleton et al. 1996) . Well-described clinical characteristics of trisomy 18 include severe psychomotor and growth restriction, microcephaly, micro-ophthalmia, micrognathia, cardiac malformations, pulmonary hypoplasia, omphalocele, ileal atresia, and adrenal hypoplasia (Edwards et al. 1960; Smith et al. 1960; Turner and O'Herlihy 1984) .
Trisomy 18 is associated with signiWcant perinatal mortality. Approximately three-quarters of fetuses diagnosed with trisomy 18 are miscarried or stillborn between 12 weeks of gestation and term (Morris and Savva 2008) . Postnatally, the median survival time is 3-6 days. Fewer than 50% of infants will survive for a week, and only about 5-10% will survive for a year (Rasmussen et al. 2003; Baty et al. 1994a ). The high mortality rate is typically due to the presence of cardiac and renal malformations, feeding diYculties that result in aspiration pneumonia, sepsis, and apnea caused by central nervous system abnormalities. Long-term survival in trisomy 18 has been reported, but this occurs primarily in the context of mosaicism (Kohn and Shohat 1987; Bettio et al. 2003) . Interestingly, in mosaic individuals there is no correlation between the physical and intellectual Wndings and the percentage of trisomic cells found in either peripheral leukocytes or skin Wbroblasts (Mewar et al. 1993) .
Unlike the well-characterized "critical region" in trisomy 21 (21q22) (Shapiro 1997; Korenberg et al. 1990) , there is no corresponding region on chromosome 18 that is associated with Edwards syndrome. The high morbidity and mortality of aVected individuals limits extensive investigation into its pathogenesis. Furthermore, studies of partially trisomic individuals performed to determine if a critical region is present in this syndrome have produced inconsistent results. For example, a case report of a patient described as having a typical full trisomy 18 phenotype showed that this individual had a duplication of 18q21.1-qter (Matsuoka et al. 1981) . Another study described patients with duplications of Xanking regions (i.e., 18q12.3-qter and 18q21.2-qter) who did not manifest the typical trisomy 18 phenotype (Turleau and de Grouchy 1977) . A clinical, cytogenetic, and molecular study of four individuals with partial duplications of the long arm of chromosome 18 concluded that either there is more than one critical region for trisomy 18, that there is no single contiguous critical region, or that the characteristic trisomy 18 phenotype could result from the additive eVect of trisomy for multiple, potentially interacting segments of 18q (Mewar et al. 1993) .
In a prior study utilizing global transcriptional proWling of RNA isolated from residual amniotic Xuid (AF) supernatant samples, we demonstrated that widespread transcriptional disruption is present in second trimester fetuses with Down syndrome, as compared to gestational age and gender-matched controls (Slonim et al. 2009 ). In the current study, using a similar approach, we investigated the in utero gene expression proWle associated with trisomy 18 to better understand the molecular mechanisms underlying the congenital anomalies observed in this condition.
Patients and methods

Patients
The Institutional Review Boards at Tufts Medical Center and Women and Infants' Hospital approved the study. Residual second trimester AF supernatant samples were obtained from women carrying singleton fetuses undergoing antenatal genetic testing for routine clinical indications. All samples were anonymized before receipt in the research laboratory, although the karyotype results and gestational ages were known. AF was stored at ¡80°C until RNA extraction. The study set consisted of AF samples with the following conWrmed metaphase karyotypes: 47,XX, + 18 (n = 5) and 46,XX (n = 6). The gestational ages of the samples ranged from 17 5/7 to 20 6/7 weeks.
RNA extraction
Total RNA was extracted from 10 mL AF supernatant with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA, USA) and 8 mL chloroform. After RNA extraction, RNA was puriWed and DNA was removed using the RNeasy ® Maxi Kit, including the DNase step, according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3 M NaOAc and 100% ethanol, and 80% ethanol was added after 4 h incubation at ¡20°C. cDNA, synthesized from extracted RNA, was ampliWed and puriWed using the WT-Ovation ™ Pico RNA ampliWcation system (NuGEN, San Carlos, CA, USA) and the DNA Clean & Concentrator ™ -25 (Zymo Research, Orange, CA, USA). The quality and quantity of ampliWed cDNA was measured on the Agilent Bioanalyzer 2100 Expert software (Agilent, Foster City, CA, USA) with the RNA 6000 Nano kit (Agilent).
Fragmentation, labeling, and hybridization
The FL-Ovation ™ cDNA Biotin Module V2 (NuGEN) was used to obtain fragmented and labeled cDNA (minimum 5 g) that was suitable for hybridization to AVymetrix U133 Plus 2.0 arrays (AVymetrix, Santa Clara, CA, USA). Arrays were washed, stained with streptavidin-phycoerythrin, scanned with the GeneArray Scanner, and analyzed using the GeneChip Microarray Suite 5.0 (AVymetrix). Array quality was assessed in R (version 2.7.2) using the simpleaVy package in BioConductor (version 1.7; www.bioconductor.org).
Data analysis and statistics
Normalization was performed with the threestep command from the AVyPLM package in BioConductor, using idealmismatch background/signal adjustment, quantile normalization, and the Tukey biweight summary method (Gentleman et al. 2005) . This summary method included a logarithmic transformation, which improved the normality of the data. IdentiWcation of individual diVerentially expressed probe sets (comparing trisomy 18 to euploid samples) was performed via two-sided t tests using the multtest package in BioConductor, with the Benjamini-Hochberg false dis-covery rate (FDR) adjustment for multiple testing (Benjamini and Hochberg 1995) . Raw and normalized data are available in NCBI's Gene Expression Omnibus (http://www. ncbi.nlm.nih.gov/geo/) under GEO series accession number GSE25634
Hierarchical clustering was performed in R, using complete-linkage hierarchical clustering (the hclust function in the stats package), and heatmaps created via the heatmap.2 function (with row z score normalization) in the gplots package.
Functional analysis of the statistically signiWcantly diVerentially regulated probe sets was performed using the Database for Annotation, Visualization, and Integrated Discovery (DAVID) toolkit, 2008 release, (Dennis et al. 2003; Huang da et al. 2009) , with the Panther functional annotation classes (Thomas et al. 2003) in addition to the default pathway selections, which include Gene Ontology (GO) terms (Ashburner et al. 2000) , pathways deWned from the Kyoto Encyclopedia of Genes and Genomes (KEGG) (Kanehisa and Goto 2000) and BioCarta (www.biocarta.com) databases, InterPro protein families (Apweiler et al. 2000) , and Protein Information Resource keywords (Barker et al. 2000) .
The diVerentially expressed AVymetrix probe set identiWers and corresponding Benjamini-Hochberg adjusted probability values were uploaded into Ingenuity Pathways Analysis (IPA) software, version 7.5 (Ingenuity ® Systems, www.ingenuity.com) to identify the networks, diseases and disorders associated with the diVerentially expressed genes. The probe sets were mapped to the corresponding IPA gene objects. These "focus" genes were combined with Ingenuity's proprietary data and knowledge base to construct a molecular network. We also used an IPA tool called "Canonical Pathways Analysis" to identify the most statistically signiWcantly over-represented pathways from the IPA pathway library in the data set (by Fischer's exact test). Graphical network models of some of the implicated pathways were generated by the IPA software, using literaturebased pathway links to connect the focus genes and other genes in the knowledge base.
Finally, diVerential expression and functional enrichment were simultaneously assessed using Gene Set Enrichment Analysis (GSEA) (Subramanian et al. 2005; Mootha et al. 2003) , software that can identify consistent diVerential expression of pre-deWned sets of genes even if the diVerential expression of each individual gene is not statistically signiWcant by itself. We ran GSEA with 500 permutations per run and with the gene-set permutation method recommended for data sets with fewer than seven samples per class (Subramanian et al. 2005) . Gene collections assessed in our GSEA experiments included groups of genes from the same chromosomal band and those with the same GO molecular function keywords (collections c1 and c5 from the Molecular Signature Database [MSigDB]) (Subramanian et al. 2005) , as well as a collection of ten gene sets related to developmental processes that we mined from published gene expression data using techniques described elsewhere (Turcan et al. 2010) .
Results
DiVerential expression in trisomy 18 versus controls
We identiWed 356 probe sets corresponding to 253 annotated genes that were statistically signiWcantly diVerentially expressed between the trisomy 18 and euploid samples (adjusted p < 0.05). We called this the "IdentiWed Gene Set" (Supplementary Table 1 ). Only seven genes (2.8% of the annotated total) were located on chromosome 18. These included LOC339290, ROCK1, ATP8B1, MGC11082, ZNF516, EMILIN2 and ONECUT2. Twenty-three genes (9.1% of the annotated total) were located on chromosome 19, which was the chromosome with the largest number of individual diVerentially regulated genes. Of the 253 annotated genes, 171 (67.6%) were up-regulated and 80 (31.6%) down-regulated in trisomy 18 compared to controls. We note that in two cases, two probe sets representing one gene (NUMA1 and KIAA1219) showed conXicting results (i.e., both up-and down-regulation). We have allowed these to remain in the data set because we do not know which result is correct. Indeed, it is even possible that the oligonucleotides chosen for the diVerent probe sets eVectively measure expression of diVerent gene variants and that both results are correct. Cluster analysis of the IdentiWed Gene Set, even excluding the few genes on chromosome 18, was suYcient to separate the euploid and trisomic samples (Fig. 1 ). In the interest of including all statistically signiWcant gene expression diVerences, we did not perform any Wltering of genes with low expression and/or low variance. We have identiWed those genes (39 of 251 annotated genes) with expression levels in the lowest decile among all of the microarray data (Supplementary Table 1 , shown in bold).
We compared the IdentiWed Gene Set in trisomy 18 to the group of 414 probe sets representing 311 annotated genes in our prior study of trisomy 21 (Slonim et al. 2009 ). We found that only six of the annotated genes were diVerentially regulated in both aneuploidies as compared to normal controls (Fig. 2 ). Of these, four (NKX1-1, CCDC85B, TTLL12, and ROCK1) were up-regulated, and two (CYP2C9 and SLC25A33) were down-regulated in both trisomies 21 and 18.
Functional analysis of diVerentially expressed genes
Pathway analysis of the IdentiWed Gene Set was performed using DAVID. Using a strict signiWcance cutoV adjusted for multiple testing (FDR <0.05), we found 28 functions over-represented in the IdentiWed Gene Set (Table 1 ). The functions disrupted in trisomy 18 include ion and cation transport, MHCII/T cell mediated immunity, DNA repair, G-protein mediated signaling, kinases, and glycosylation. In addition, DAVID's clustering function highlighted groups of related gene sets that were diVerentially regulated; these included cytoskeletal and cell adhesion proteins, zinc Wnger proteins, notch signaling, immunoglobulin-like proteins, and neurological development.
To further characterize the relationships between diVerentially regulated genes, we used IPA to examine the 80 down-regulated genes and the 171 up-regulated genes. For down-regulated genes, all associated network functions that included more than one focus gene are shown in Table 2 . The top associated network among the down-regulated genes involved "organismal function," which included pathways associated with adrenal gland development. Other network functions included cardiovascular and respiratory system development, function, and disease. Regarding adrenal development, the top down-regulated gene network included 35 genes, 17 of them focus genes (Fig. 3) . Further characterization of this network identiWed 8 genes related to canonical pathways with functions that include signaling for corticotropin releasing hormone (CRH), epidermal growth factor (EGF), Wbroblast growth factor (FGF), and insulin like growth factor-one (IGF-1); all are required for normal morphological and functional development of the fetal adrenal cortical zone after 15 gestational weeks (Kempná and Flück 2008) .
For up-regulated genes, all associated network functions that included more than one focus gene are shown in Table 3 . The most signiWcantly associated network identiWed among the up-regulated genes was comprised of 35 genes, of which 22 were focus genes. Further functional analysis of these 35 genes identiWed pathways related to cardiovascular development, function, and disease, although IPA did not categorize this as one of the "top" functions associated with these genes (Table 3) . Rather, these network functions were identiWed by IPA as endocrine function, lipid metabolism and molecular transport. Nevertheless, ROCK1, a gene that is known to be involved in cardiac development and was statistically signiWcantly up-regulated in both trisomies 18 and 21 was included in this network. Other networks identiWed by IPA included immunological and neurological system development, function, and disease (Table 3) .
DiVerentially expressed gene sets
Examining expression variation in predeWned sets of genes can help to detect consistent expression changes that might be missed by a gene-by-gene analytic approach. Accordingly, we used the GSEA package to look for diVerential expression of gene sets corresponding to each chromosomal band (Subramanian et al. 2005 ). The only signiWcantly up-regulated set of genes (with an FDR q < 0.05) was the set of genes from chromosomal band 18q22 (q < 0.033). The next two most-signiWcantly up-regulated gene sets were from two other bands on chromosome 18, 18p11 (q < 0.085), and 18q11 (q < 0.216). In addition, we looked for dysregulation of gene sets from the molecular function gene set collection (c5 from MSigDB), which contains sets of genes with the same GO molecular function keywords. Although none of these gene sets was over-represented with FDR q value below 0.05, several were up-regulated in the trisomy 18 samples with q values between 0.10 and 0.25. Such q values are still of potential interest (Subramanian et al. 2005) . Among these were several groups related to neurotransmitters (including G protein coupled receptors and sodium channel activity) and cytokine/chemokine activity.
Finally, we looked for diVerential expression in a collection of ten gene sets that we had previously mined from public data with the speciWc goal of better characterizing fetal developmental processes. We found that one of these ten gene sets was signiWcantly up-regulated in the trisomy 18 samples with an FDR q value below 0.002. Since little is known about the functional roles of the genes in this set, we selected the 79 genes (Supplemental Table 2 ) in its "leading edge" gene set (the genes that contributed the most to the enrichment statistic calculated by the GSEA algorithm) (Subramanian et al. 2005) and performed a functional analysis of these genes in DAVID using the methods described earlier. Nine of the 79 leading edge genes have expression levels in the lowest decile among all data; these appear in boldface in Supplementary Table 2. SigniWcantly enriched functions in this diVerentially expressed developmental gene set include lipid, fatty acid and steroid metabolism and signal transduction.
Discussion
DiVerential gene expression analysis
In this study we used cell-free fetal RNA in AF supernatant to perform developmental gene expression analysis in second trimester fetuses with trisomy 18, and compared the (2007) ; histone H3b (H3F3B), nuclear factor I/B (NFIB), protein phosphatase 1 (PPP1R7), and two hypothetical proteins. This lack of overlap between the gene lists from the two studies is most likely a reXection of the diVerent biological material used, as their analysis was of RNA isolated from amnion and chorionic villus cells in culture, while ours was of RNA from AF supernatant, which is hypothesized to represent a variety of fetal tissue types (Hui and Bianchi 2010) . Indeed, we suggest that transcriptomic analysis of the supernatant fraction of AF is more appropriate and valuable for the assessment of fetal development than the cellular fraction due to the representation of various organ systems (e.g., respiratory, gastrointestinal, urinary, skin) in the cell-free component of AF (Hui and Bianchi 2010) . It also has an advantage over other maternal body Xuids, speciWcally plasma or serum, for monitoring fetal development in that the RNA in AF supernatant is exclusively fetal in origin. These results have both similarities to and diVerences from those of a prior study in which we analyzed gene expression in cell-free AF from fetuses with trisomy 21 (Slonim et al. 2009 ). In that study, only Wve of over three hundred individually diVerentially expressed annotated genes (1.6%) were located on chromosome 21, but GSEA also implicated coordinated up-regulation of gene sets from the aneuploid chromosome. The speciWc diVerentially regulated genes identiWed for trisomies 18 and 21, however, were largely diVerent from each other. The fact that each aneuploidy had hundreds of non-overlapping diVerentially regulated genes (as compared to euploid fetuses) suggests that each aneuploidy has a speciWc unique molecular phenotype. Interestingly, while only six annotated genes were diVerentially regulated in both trisomy 18 and 21 compared to controls, the expression diVerences for these genes were in the same direction for both aneuploidies. It is unclear at present whether this represents random chance or common mechanisms. However, at least one of these genes (ROCK1, discussed below) is involved in the development of an organ system (cardiovascular) that is abnormal in both aneuploidies. The possibility of gene expression changes representing common mechanisms between diVerent genetic anomalies warrants further investigation.
Pathway and functional analyses
Endocrine system IPA speciWcally implicated adrenal gland development among the down-regulated pathways in the trisomy 18 samples. Gross and microscopic hypoplasia of the adrenal cortical zone has previously been reported in autopsy studies of fetuses with trisomy 18 (Turner and O'Herlihy 1984) . This study suggested that adrenal cortical hypofunction is a frequent, but generally underappreciated, feature of trisomy 18. In the Wrst trimester, fetal adrenal growth is independent of adrenocorticotropic hormone (ACTH). After 15 weeks, while ACTH is required for normal morphological and functional development, other factors of fetal and/or placental origin are also needed (Langlois et al. 2002) . These include FGF, EGF, and IGF-1, which were all implicated by the IPA network analysis as down-regulated in the trisomy 18 samples. We suggest, therefore, that abnormal gene expression related to the adrenal network may contribute to the growth restriction that is known to be an antenatal and postnatal feature of trisomy 18. Furthermore, this may explain the abnormal maternal serum estriol levels that are found in this condition. Unfortunately, due to patient conWdentiality issues, we only had karyotype information but no clinical follow-up on study subjects. Thus, we were unable to examine the adrenal glands from fetuses with trisomy 18 in the present study, but we propose such analysis as future work. It was intriguing to discover that in addition to the genes described above that were down-regulated and known to be associated with adrenal gland development, other genes involved in endocrine system development and function were found to be up-regulated in trisomy 18. These results may suggest an overall dysregulation of gene expression involving aVected organ systems in trisomy 18. However, further investigation is needed to determine how diVerent genes within a speciWc pathway or organ system interact (e.g., if gene expression levels are aVected by feedback mechanisms).
Cardiovascular system
The top IPA network of 35 up-regulated genes highlighted pathways related to cardiovascular disease. SpeciWcally, Rho-associated kinase 1 (ROCK1) was both signiWcantly up-regulated and located on chromosome 18. ROCKs, the immediate downstream targets of RhoA, consist of two isoforms, and are ubiquitously expressed serine-threonine protein kinases involved in diverse cellular functions, including smooth muscle contraction, actin cytoskeleton organization, cell adhesion and motility, and gene expression (Ichizaki et al. 1996; Leung et al. 1985; Matsui et al. 1996) . During early heart development, endothelial cells in the outXow tract and atrioventricular regions transform into mesenchyme that ultimately becomes endocardial cushion tissue. ROCK1 plays an important role in the regulation of endocardial cell diVerentiation and migration (Zhao and Rivkees 2004; Sakabe et al. 2006 ) SpeciWcally, ROCK1 is up-regulated at the onset of the epithelial-mesenchyme transition phase in the heart (Sakabe et al. 2008) . The fact that ROCK1 is up-regulated in both trisomies 18 and 21, and that both valvular and endocardial cushion abnormalities are found in these conditions, is intriguing and suggests a common mechanism. Furthermore, a PubMed search indicated that ROCK1 has never previously been associated with trisomy 18 in the literature. This highlights one of the beneWts of our discovery-driven approach.
Lipid metabolism
Given that fetuses and neonates with trisomy 18 have been demonstrated to have abnormally low AF and plasma cholesterol levels (Lam et al. 2006) , it was surprising to Wnd that a developmental gene set involved in lipid, fatty acid, and steroid metabolism was up-regulated in the aneuploid fetuses. We speculate that there may be a feedback mechanism that relates the low cholesterol levels to up-regulation of speciWc genes. Hypocholesterolemia is a feature of Smith-Lemli-Opitz syndrome (Irons et al. 1993 ), a condition that shares phenotypic features with trisomy 18 such as growth restriction, developmental delay, and under-masculinization of male fetuses.
Immune regulation
Gene sets implicated in T cell mediated immunity were shown to be highly diVerentially expressed between the trisomy 18 samples and the controls. The immunological consequences of trisomy 18 are substantial, as infection is a common cause of morbidity in long-term survivors (Van Dyke and Allen 1990) . Trisomy 18 fetuses have signiWcantly lower mean T cell and natural killer cell counts than euploid fetuses, although the mean B cell count is not signiWcantly aVected (Makrydimas et al. 1994) . The identiWcation of speciWc diVerentially expressed gene sets related to immune function in this population might facilitate discovery of the proximate causes of the reduced immune function associated with trisomy 18. In time this might lead to better clinical management of infections and pneumonia in surviving patients.
Central nervous system
Long-term survivors with trisomy 18 have severe developmental delay (Baty et al. 1994b) . A number of neurological developmental pathways were implicated in our analysis, suggesting possible mechanisms for the disruption of neurological development. One possibility is that dysregulation of ion transport proteins due to the downstream eVects of increased gene dosage on chromosome 18 interferes with the cells' ability to manage oxidative stress, with consequences for neurological development (Kourie 1998) .
Conclusions
In summary, the present study contributes novel information regarding developmental gene expression diVerences between second trimester fetuses aVected with trisomy 18 and matched euploid controls. Most of the speciWc transcriptional eVects of trisomy 18 identiWed were due to dysregulated genes on chromosomes other than 18. This "downstream eVect" is consistent with prior studies of transcriptional diVerences in both chorionic villi in fetuses with trisomy 18 and cell-free AF supernatant in fetuses with trisomy 21. Further analyses of these results may lead to a new understanding of the molecular aspects of both the trisomy 18 phenotype as well as the isolated congenital anomalies that are observed in trisomy 18 but can also present in euploid fetuses.
